Biomark Diagnostics Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 19, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	37	14	17	10	11	21
Market Cap Growth	214.86%	-15.29%	61.96%	-7.18%	-45.46%	140.92%
Enterprise Value	37	15	18	12	12	21
Last Close Price	0.35	0.14	0.19	0.13	0.14	0.27
PS Ratio	652.61	145.04	152.12	100.50	356.91	-
PB Ratio	117.89	12.85	-40.73	-13.42	-24.67	-386.98
P/TBV Ratio	117.89	12.85	-	-	-	-
EV/Sales Ratio	-	154.52	161.35	110.73	393.16	-
Debt / Equity Ratio	1.40	0.64	-2.54	-1.44	-3.09	-12.70
Net Debt / Equity Ratio	-1.13	-0.78	-2.28	-1.37	-2.49	-1.61
Net Debt / EBITDA Ratio	0.29	0.67	-0.82	-0.86	-1.24	-0.12
Net Debt / FCF Ratio	0.28	1.24	-1.41	-1.72	-1.25	-0.16
Asset Turnover	0.06	0.07	0.18	0.14	0.04	-
Quick Ratio	1.20	2.14	0.16	0.06	0.31	0.98
Current Ratio	1.20	2.14	0.16	0.08	0.33	1.00
Return on Equity (ROE)	-	-340.70%	-	-	-	-
Return on Assets (ROA)	-81.70%	-60.59%	-117.29%	-104.38%	-66.20%	-80.77%
Return on Capital Employed (ROCE)	-218.40%	-107.60%	1099.30%	197.40%	4328.70%	-3366.60%
Earnings Yield	-2.84%	-8.62%	-5.75%	-11.94%	-9.27%	-3.57%
FCF Yield	-3.42%	-4.90%	-3.98%	-5.96%	-8.06%	-2.64%
Buyback Yield / Dilution	84.66%	-6.67%	-2.97%	-6.22%	-6.31%	-2.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.